HOME >> MEDICINE >> NEWS
GroPep to pursue promising asthma drug following preclinical study results

Adelaide biotechnology company GroPep has completed preclinical efficacy studies of its T-cell peptide drug candidate, in models of psoriasis and asthma.

GroPep will undertake a market feasibility assessment for the use of the drug in asthma but will cease development for psoriasis.

Current annual sales of asthma drugs in the United States alone exceed US$4.0 billion and are growing at over 10%. GroPep has international patent coverage for the T-cell peptide technology.

Listed biopharmaceutical company GroPep Limited (ASX: GRO) announced today that it had completed testing of its T-cell peptide drug candidate in preclinical models of asthma and psoriasis.

The results showed that the drug was highly effective in treating asthma but had little effect in a model of psoriasis when applied to the skin, even in an efficient formulation. As a result, the Company will direct its resources in the highly profitable field of immune-based diseases towards asthma, and will cease development for psoriasis.

As previously reported by the Company, initial research conducted at the Royal North Shore Hospital, Sydney by Professor Manolios showed the drug has potential in a range of autoimmune diseases.

Exclusive, worldwide rights to key patents covering the drug were obtained by GroPep in 2002, through a licence from the Northern Sydney and Central Coast Area Health Service.

In May 2005, GroPep filed a new International Patent Application on the use of the drug for the treatment of asthma, based on the work of Professor Enk at the University of Mainz, Germany Asthma affects more than 15 million people in the US alone and 100 million people worldwide. The market is increasing because of an ageing population and the contribution of pollution, smoking and airborne allergens. Current sales of asthma drugs in the United States alone exceed US$4.0 billion and are growing annually at over 10%.

GroPep's Chief Operat
'"/>

Contact: Tony Mitchell
61-883-547-700
Research Australia
14-Dec-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Half of active children pursue non-traditional physical activities
7. ICSU pursues new initiative that challenges science to do more to prevent natural disasters
8. Study shows Philip Morris pursued tobacco regulation to enhance its image
9. Study: Directly observed HIV therapy for children is promising
10. Childhood obesity intervention shows promising results
11. Animal study identifies promising new target for brain tumor therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... Calif. (PRWEB) , ... November 11, 2019 , ... ... of business support services to dental groups in the United States, today announced ... the community of Lodi, CA. , Patients will enjoy convenient hours, comfortable offices ...
(Date:11/11/2019)... ... November 11, 2019 , ... Artemis, ... illness prevention and urges increased adoption of compliance technology in the wake of ... products sold to select retailers in the United States and Canada due to ...
(Date:11/9/2019)... ... November 08, 2019 , ... Pennsylvania ... is pleased to announce that after the fourth quarter of the 2018-2019 academic ... a 94.73% average pass rate. The College’s annual pass rate for the 2018-2019 ...
(Date:11/7/2019)... ... November 06, 2019 , ... An October 13 article on Yahoo ... to the article, while no U.S. state had an obesity rate above 15 percent ... obese. The article cites quite a few reasons for this rise, including eating out ...
(Date:11/7/2019)... ... ... to announce that the Medical Spa Show 2020 exhibit hall floor has been sold out ... “Every year, we have expanded the size of the floor to accommodate all of the ... options for attendees, and this year is no exception. The exhibit hall floor is 50% ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... Doral Health & Wellness, ... Adult Day Care Center on Pitkin Avenue in the Brownsville section of Brooklyn. ... managing and preventing diabetes. Seniors can take part in fitness and meditation classes, ...
(Date:11/6/2019)... ... November 06, 2019 , ... On ... Westchester Hospital (NWH) President and CEO, Joel Seligman, with the Make A Difference ... commitment to raising awareness, providing education and registering lifesaving donors. Assemblyman David Buchwald, ...
(Date:11/5/2019)... Va. (PRWEB) , ... November ... ... Interactive Workshops, Wednesday-Thursday, Nov. 13-14: How to Build a Sponsor Risk Management ... Resources International, Inc., Wednesday-Friday, Nov. 13-15, 2019 • Philadelphia, PA , ...
Breaking Medicine Technology:
Cached News: